Insider · CIK 0001861878

YVER ANTOINE

Reports to the SEC for 1 company · CHESHIRE, X0

sec.gov

Transactions

Companies

Filings

CIK

0001861878

Forms 4 and 5

Insider transactions

26 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-06-01	Centessa Pharmaceuticals plcS Sale	EVP & Chairman of Development	SSale	−6,500 sh	$4.45	−$28.9K	783,066
2023-05-01	Centessa Pharmaceuticals plcS Sale	EVP & Chairman of Development	SSale	−6,800 sh	$4.42	−$30.1K	789,566
2023-04-03	Centessa Pharmaceuticals plcS Sale	EVP & Chairman of Development	SSale	−6,700 sh	$3.69	−$24.7K	796,366
2023-03-31	Centessa Pharmaceuticals plcF Tax Payment	EVP & Chairman of Development	FTax Payment	−3,615 sh	$3.90	−$14.1K	803,066
2023-03-01	Centessa Pharmaceuticals plcS Sale	EVP & Chairman of Development	SSale	−7,000 sh	$3.42	−$24K	806,681
2023-02-01	Centessa Pharmaceuticals plcA Award	EVP & Chairman of Development	AAward	+77.2K sh	—	—	821,381
2023-02-01	Centessa Pharmaceuticals plcS Sale	EVP & Chairman of Development	SSale	−7,700 sh	$3.79	−$29.2K	813,681
2023-02-01	Centessa Pharmaceuticals plcShare Option (right to buy)A Award	EVP & Chairman of Development	AAward	+115K sh	—	—	115,000
2023-01-04	Centessa Pharmaceuticals plcS Sale	EVP & Chairman of Development	SSale	−6,970 sh	$3.18	−$22.1K	751,913
2022-12-31	Centessa Pharmaceuticals plcF Tax Payment	EVP & Chairman of Development	FTax Payment	−2,268 sh	$3.10	−$7,030.8	758,883
2022-12-01	Centessa Pharmaceuticals plcS Sale	EVP & Chairman of Development	SSale	−9,400 sh	$3.91	−$36.7K	761,151
2022-11-01	Centessa Pharmaceuticals plcS Sale	EVP & Chairman of Development	SSale	−9,700 sh	$4.03	−$39.1K	765,059
2022-10-03	Centessa Pharmaceuticals plcS Sale	EVP & Chairman of Development	SSale	−9,500 sh	$3.91	−$37.1K	780,251
2022-10-03	Centessa Pharmaceuticals plcS Sale	EVP & Chairman of Development	SSale	−12.5K sh	$3.92	−$49.1K	774,759
2022-09-30	Centessa Pharmaceuticals plcF Tax Payment	EVP & Chairman of Development	FTax Payment	−7,732 sh	$4.25	−$32.9K	782,019
2022-09-30	Centessa Pharmaceuticals plcS Sale	EVP & Chairman of Development	SSale	−2,468 sh	$4.07	−$10K	787,283
2022-09-01	Centessa Pharmaceuticals plcS Sale	EVP & Chairman of Development	SSale	−10.4K sh	$4.41	−$46K	789,751
2022-08-01	Centessa Pharmaceuticals plcS Sale	EVP & Chairman of Development	SSale	−10.4K sh	$4.45	−$46.4K	800,174
2022-07-18	Centessa Pharmaceuticals plcS Sale	EVP & Chairman of Development	SSale	−20K sh	$4.87	−$97.3K	810,597
2022-07-01	Centessa Pharmaceuticals plcS Sale	EVP & Chairman of Development	SSale	−9,100 sh	$5.03	−$45.8K	730,597
2022-07-01	Centessa Pharmaceuticals plcA Award	EVP & Chairman of Development	AAward	+100K sh	—	—	830,597
2022-06-17	Centessa Pharmaceuticals plcS Sale	EVP & Chairman of Development	SSale	−9,200 sh	$4.68	−$43K	739,697
2022-05-18	Centessa Pharmaceuticals plcS Sale	EVP & Chairman of Development	SSale	−64.8K sh	$5.10	−$330K	748,897
2022-05-17	Centessa Pharmaceuticals plcS Sale	EVP & Chairman of Development	SSale	−20.2K sh	$5.42	−$110K	813,675
2022-02-01	Centessa Pharmaceuticals plcShare Option (right to buy)A Award	EVP & Chairman of Development	AAward	+200K sh	—	—	200,000
2021-05-27	Centessa Pharmaceuticals plcA Award	EVP & Chairman of Development	AAward	+834K sh	—	—	833,897

Recent filings

Accepted (ET)
Jun 24
YVER ANTOINE0001847903-23-000104
SEC(opens sec.gov)
May 24
YVER ANTOINE0001847903-23-000090
SEC(opens sec.gov)
Apr 44
YVER ANTOINE0001847903-23-000082
SEC(opens sec.gov)
Mar 34
YVER ANTOINE0001847903-23-000054
SEC(opens sec.gov)
Feb 34
YVER ANTOINE0001847903-23-000045
SEC(opens sec.gov)
Jan 134
YVER ANTOINE0001847903-23-000025
SEC(opens sec.gov)
Jan 44
YVER ANTOINE0001847903-23-000016
SEC(opens sec.gov)
Dec 54
YVER ANTOINE0001847903-22-000109
SEC(opens sec.gov)
Nov 234/A
YVER ANTOINE0001847903-22-000096
SEC(opens sec.gov)
Nov 34
YVER ANTOINE0001847903-22-000076
SEC(opens sec.gov)
Oct 44
YVER ANTOINE0001847903-22-000065
SEC(opens sec.gov)
Sep 24
YVER ANTOINE0000899243-22-030302
SEC(opens sec.gov)
Aug 34
YVER ANTOINE0000899243-22-027633
SEC(opens sec.gov)
Jul 204
YVER ANTOINE0000899243-22-026421
SEC(opens sec.gov)
Jul 64
YVER ANTOINE0000899243-22-025479
SEC(opens sec.gov)

Companies

Centessa Pharmaceuticals plcEVP & Chairman of Development

Address

C/O CENTESSA PHARMACEUTICALS PLC 3RD FL., 1 ASHLEY RD, ALTRINCHAM

CHESHIRE, X0, WA14 2DT